{"id":27969,"date":"2021-02-01T22:13:00","date_gmt":"2021-02-01T22:13:00","guid":{"rendered":""},"modified":"2021-02-01T22:13:00","modified_gmt":"2021-02-01T22:13:00","slug":"pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/","title":{"rendered":"PR NEWSWIRE – ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o “Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta” e anunciam hoje o lan\u00e7amento global do aplicativo gratuito “R Plus Health”"},"content":{"rendered":"
\n

CF PharmTech e Chengdu Shangyi lan\u00e7am o “Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta” e anunciam hoje o lan\u00e7amento global do aplicativo gratuito “R Plus Health”<\/h1>\n

PR Newswire<\/p>\n

SUZHOU, China, 1 de fevereiro de 2021<\/p>\n<\/div>\n

\nSUZHOU, China<\/span>, 1\u00a0de fevereiro de 2021 \/PRNewswire\/ — A CF PharmTech, Inc. \u00e9 uma empresa farmac\u00eautica inteiramente integrada na China<\/span>, dedicada ao tratamento de doen\u00e7as respirat\u00f3rias. A Chengdu Shangyi Information Technology Co., Ltd \u00e9 uma empresa de servi\u00e7os profissionais de TI no setor de sa\u00fade na China<\/span>.<\/p>\n
\n<\/a><\/p>\n<\/div>\n

Em abril de 2020, a CF PharmTech e a Chengdu Shangyi lan\u00e7aram o “Programa de recupera\u00e7\u00e3o em casa para pacientes de Covid-19 que tiveram alta”. Sob a orienta\u00e7\u00e3o do Professor Li Jian<\/span>‘an, membro da Academia Americana de Ci\u00eancias M\u00e9dicas e Diretor do Centro M\u00e9dico de Reabilita\u00e7\u00e3o do Primeiro Hospital Afiliado da Universidade de Ci\u00eancias M\u00e9dicas de Nanjing<\/span>, as empresas conduziram com sucesso estudos de pacientes de Covid-19 que tiveram alta usando o monitoramento remoto de reabilita\u00e7\u00e3o esportiva por meio do aplicativo “R Plus Health”. <\/p>\n

Os resultados cl\u00ednicos superaram as expectativas de todos. O Professor Li Jian<\/span>‘an concluiu que o efeito do monitoramento de reabilita\u00e7\u00e3o esportiva para pacientes que utilizam o aplicativo foi compar\u00e1vel ao efeito do atendimento dispensado aos pacientes no “Hospital de Campanha” em Wuhan<\/span>. Em conjunto, as empresas lan\u00e7am, hoje, o aplicativo gratuito “R Plus Health” em todo o mundo.<\/p>\n

O aplicativo \u00e9 o tratamento de recupera\u00e7\u00e3o domiciliar clinicamente comprovado e eficaz em todo o mundo para pacientes de Covid-19. \u00c9 a primeira “terapia digital patenteada” aprovada pela NMPA (National Medical Products Administration, Administra\u00e7\u00e3o Nacional de Produtos M\u00e9dicos). A principal fun\u00e7\u00e3o do aplicativo \u00e9 sua avalia\u00e7\u00e3o cardiopulmonar\/muscular\/nutricional inteligente remota, aliando o equipamento “wearable” com suplementos medicinais pr\u00e9-embalados.<\/p>\n

O aplicativo ajudar\u00e1 a melhorar a resist\u00eancia cardiopulmonar e a imunidade dos pacientes de Covid-19, popula\u00e7\u00f5es suscet\u00edveis, contatos de alto risco, pessoas idosas e crian\u00e7as com imunidade deficiente. Assim que os usu\u00e1rios se cadastram, o aplicativo realiza avalia\u00e7\u00f5es inteligentes, incluindo question\u00e1rios e testes de resist\u00eancia cardiopulmonar e de fun\u00e7\u00e3o corporal. Ap\u00f3s uma avalia\u00e7\u00e3o, os usu\u00e1rios podem acessar um programa de exerc\u00edcios personalizado, incluindo tipo de esporte, intensidade, dura\u00e7\u00e3o e frequ\u00eancia. Basta seguir os v\u00eddeos de treinamento esportivo e praticar os exerc\u00edcios. O resultado ser\u00e1 aprimorado se o aplicativo estiver conectado a um equipamento inteligente.<\/p>\n

Desde o surto de Covid-19, mais de 100 milh\u00f5es de pessoas foram diagnosticadas em todo o mundo e o n\u00famero de indiv\u00edduos infectados est\u00e1 aumentando rapidamente. A Covid-19 tornou-se uma pandemia global. Inscreva-se no aplicativo “R Plus Health” para aprimorar o condicionamento f\u00edsico, melhorar a imunidade e combater o coronav\u00edrus.<\/p>\n

Como baixar:
1.\u00a0Pesquise o aplicativo “R Plus Health” na Apple Store ou no Google Play
2.\u00a0Clique no link: https:\/\/download.rplushealth.cn\/app\/patient<\/a>\u00a0 <\/p>\n

Foto – https:\/\/mma.prnewswire.com\/media\/1430479\/1.jpg<\/a><\/p>\n

\u00a0<\/p>\n

<\/div>\n

FONTE CF PharmTech, Inc.<\/p>\n<\/div>\n

\"\"<\/p>\n

PR NEWSWIRE<\/p>\n","protected":false},"excerpt":{"rendered":"CF PharmTech e Chengdu Shangyi lan\u00e7am o “Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta” e anunciam hoje o lan\u00e7amento global do aplicativo gratuito","protected":false},"author":1,"featured_media":27970,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[29],"tags":[],"class_list":["post-27969","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-prnewseconomia"],"acf":[],"yoast_head":"\nPR NEWSWIRE - ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o "Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta" e anunciam hoje o lan\u00e7amento global do aplicativo gratuito "R Plus Health" - Ag\u00eancia de Comunica\u00e7\u00e3o<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PR NEWSWIRE - ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o "Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta" e anunciam hoje o lan\u00e7amento global do aplicativo gratuito "R Plus Health" - Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"og:description\" content=\"CF PharmTech e Chengdu Shangyi lan\u00e7am o “Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta” e anunciam hoje o lan\u00e7amento global do aplicativo gratuito\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/\" \/>\n<meta property=\"og:site_name\" content=\"Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-01T22:13:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2019\/12\/medialabimagem-1545.png\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"patric_oliveira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"patric_oliveira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/\"},\"author\":{\"name\":\"patric_oliveira\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"headline\":\"PR NEWSWIRE – ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o “Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta” e anunciam hoje o lan\u00e7amento global do aplicativo gratuito “R Plus Health”\",\"datePublished\":\"2021-02-01T22:13:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/\"},\"wordCount\":551,\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/medialabimagem-1545.png\",\"articleSection\":[\"PR Newswire Economia\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/\",\"name\":\"PR NEWSWIRE - ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o \\\"Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta\\\" e anunciam hoje o lan\u00e7amento global do aplicativo gratuito \\\"R Plus Health\\\" - Ag\u00eancia de Comunica\u00e7\u00e3o\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/medialabimagem-1545.png\",\"datePublished\":\"2021-02-01T22:13:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/medialabimagem-1545.png\",\"contentUrl\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/medialabimagem-1545.png\",\"width\":600,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PR NEWSWIRE – ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o “Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta” e anunciam hoje o lan\u00e7amento global do aplicativo gratuito “R Plus Health”\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\",\"name\":\"Ag\u00eancia de Comunica\u00e7\u00e3o\",\"description\":\"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\",\"name\":\"patric_oliveira\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"caption\":\"patric_oliveira\"},\"sameAs\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"],\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/author\\\/patric_oliveira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PR NEWSWIRE - ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o \"Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta\" e anunciam hoje o lan\u00e7amento global do aplicativo gratuito \"R Plus Health\" - Ag\u00eancia de Comunica\u00e7\u00e3o","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/","og_locale":"pt_BR","og_type":"article","og_title":"PR NEWSWIRE - ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o \"Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta\" e anunciam hoje o lan\u00e7amento global do aplicativo gratuito \"R Plus Health\" - Ag\u00eancia de Comunica\u00e7\u00e3o","og_description":"CF PharmTech e Chengdu Shangyi lan\u00e7am o “Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta” e anunciam hoje o lan\u00e7amento global do aplicativo gratuito","og_url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/","og_site_name":"Ag\u00eancia de Comunica\u00e7\u00e3o","article_published_time":"2021-02-01T22:13:00+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2019\/12\/medialabimagem-1545.png","type":"image\/png"}],"author":"patric_oliveira","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"patric_oliveira","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/#article","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/"},"author":{"name":"patric_oliveira","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"headline":"PR NEWSWIRE – ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o “Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta” e anunciam hoje o lan\u00e7amento global do aplicativo gratuito “R Plus Health”","datePublished":"2021-02-01T22:13:00+00:00","mainEntityOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/"},"wordCount":551,"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/#primaryimage"},"thumbnailUrl":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2019\/12\/medialabimagem-1545.png","articleSection":["PR Newswire Economia"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/","name":"PR NEWSWIRE - ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o \"Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta\" e anunciam hoje o lan\u00e7amento global do aplicativo gratuito \"R Plus Health\" - Ag\u00eancia de Comunica\u00e7\u00e3o","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/#primaryimage"},"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/#primaryimage"},"thumbnailUrl":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2019\/12\/medialabimagem-1545.png","datePublished":"2021-02-01T22:13:00+00:00","author":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"breadcrumb":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/#primaryimage","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2019\/12\/medialabimagem-1545.png","contentUrl":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-content\/uploads\/2019\/12\/medialabimagem-1545.png","width":600,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/pr-newswire-economia-e-negocios-cf-pharmtech-e-chengdu-shangyi-lancam-o-programa-de-recuperacao-domiciliar-para-pacientes-de-covid-19-que-tiveram-alta-e-anunciam-hoje-o-lancamento-global-do-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"},{"@type":"ListItem","position":2,"name":"PR NEWSWIRE – ECONOMIA E NEG\u00d3CIOS :: CF PharmTech e Chengdu Shangyi lan\u00e7am o “Programa de recupera\u00e7\u00e3o domiciliar para pacientes de Covid-19 que tiveram alta” e anunciam hoje o lan\u00e7amento global do aplicativo gratuito “R Plus Health”"}]},{"@type":"WebSite","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/","name":"Ag\u00eancia de Comunica\u00e7\u00e3o","description":"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37","name":"patric_oliveira","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","caption":"patric_oliveira"},"sameAs":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"],"url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/author\/patric_oliveira\/"}]}},"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/27969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=27969"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/27969\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media\/27970"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=27969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=27969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=27969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}